39 results on '"Villarroel, Claudio"'
Search Results
2. Impact of Polycystic Ovary Syndrome, Metabolic Syndrome, Obesity, and Follicular Growth Arrest in Women Health
3. Geospatial analysis of cardiovascular mortality before and during the COVID-19 pandemic in Peru: analysis of the national death registry to support emergency management in Peru.
4. Лікування симптомів міоми матки з використанням комбінованої терапії релюголіксом.
5. A plain language summary of the long-term relugolix combination therapy study for uterine fibroids
6. Relugolix Combination Improves Quality of Life in Phase 3 Studies of Symptomatic Uterine Fibroids [OP04-4D]
7. A Plain Language Summary of the Safety of Relugolix Combination Therapy and Improvement in Symptoms in Women with Uterine Fibroids from the LIBERTY 1 and LIBERTY 2 Studies
8. Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas
9. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls
10. Treatment of Uterine Fibroid Symptoms With Relugolix Combination Therapy
11. Polycystic Ovarian Morphology (PCOM) in Adolescents with Regular Menstrual Cycles Is Associated with Elevated Anti-Müllerian Hormone (AMH): Impact of Different Diagnostic Criteria
12. Elevated anti-Müllerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus
13. LIBERTY: LONG-TERM EXTENSION STUDY DEMONSTRATING ONE-YEAR EFFICACY AND SAFETY OF RELUGOLIX COMBINATION THERAPY IN WOMEN WITH SYMPTOMATIC UTERINE FIBROIDS
14. QUALITY-OF-LIFE IMPROVEMENT WITH RELUGOLIX COMBINATION THERAPY IN PATIENTS WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS: RESULTS FROM THE LIBERTY PHASE 3 PROGRAM
15. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome
16. Hormonal Profile in Women with Polycystic Ovarian Syndrome with or without Type 1 Diabetes Mellitus
17. Treatment of symptoms of uterine fibroids with relugolix combination therapy: efficacy and safety results from the phase 3 liberty 1 clinical trial
18. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls
19. The use of long-acting reversible contraceptives in Latin America and the Caribbean: current landscape and recommendations
20. Anti-Müllerian hormone in type 2 and gestational diabetes during the second half of pregnancy: relationship with sexual steroid levels and metabolic parameters
21. Hyperandrogenism in adolescent girls: relationship with the somatotrophic axis
22. New Diagnostic Criteria of Polycystic Ovarian Morphology for Adolescents: Impact on Prevalence and Hormonal Profile
23. Pregestational type 2 diabetes and gestational diabetes exhibit different sexual steroid profiles during pregnancy
24. Anti-Müllerian hormone in type 2 and gestational diabetes during the second half of pregnancy: relationship with sexual steroid levels and metabolic parameters.
25. Glucotransporters expression and function in the human endometrium from normal and polycystic ovary syndrome women: Effect of metformin treatment
26. Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents
27. Pregestational type 2 diabetes and gestational diabetes exhibit different sexual steroid profiles during pregnancy.
28. Transient expression of progesterone receptor and cathepsin-l in human granulosa cells during the periovulatory period
29. Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation
30. Polycystic ovarian morphology in postmenarchal adolescents
31. Response to the Letter to the Editor
32. Ovarian function in adolescents with McCune-Albright syndrome
33. Elevated anti‐Müllerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus
34. Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation
35. Assessment of diagnostic competence of plasmatic androgens on polycystic ovary syndrome based on receiver operator characteristic curves
36. Deterioro cognitivo leve y enfermedad de Alzheimer inicial en adultos mayores
37. Deterioro cognitivo leve y enfermedad de Alzheimer inicial en adultos mayores
38. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls
39. Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.